Introduction of sacubitril/valsartan in primary care follow-up of heart failure: a prospective observational study (THESEUS).
Thomas DieterleStefan SchaeferIna MeyerGabriele AckermannKashan AhmedRoger HullinPublished in: ESC heart failure (2020)
Results from THESEUS suggest that transition to sac/val is manageable in primary care, with a safety profile corresponding to reports from specialized heart failure care.